PIONEER, EHDEN and OHDSI join forces to study the clinical management of prostate cancer in a virtual studyathon Prostate cancer is a major disease affecting more than 2 million men in Europe alone, and has now become the most common cancer in men. Clinical management of this complex disease is challenging and involves difficult trade-offs, … Read more
Each year at their annual Symposium, OHDSI recognises collaborators or collaborating institutions that contribute to their mission. Colleagues from across the EHDEN community won Titan awards in all categories at this year’s Symposium, reinforcing the calibre of expertise also within EHDEN as recognised by the OHDSI Community itself.
Designed jointly by EHDEN and OHDSI, the Data Quality Dashboard (DQD) debuted last August with the National COVID Cohort Collaborative, which is an initiative funded by the United States National Institutes of Health (NIH). The NIH is the largest biomedical research agency in the world and is part of the United States Department of Health … Read more
The 6th Annual OHDSI Symposium will feature everything that makes our event an annual highlight for so many community members, including plenary sessions, tutorials and the Collaborator Showcase, as well as a two-day study-a-thon, where we will bring our global community together to collaboratively generate real-world evidence on an important healthcare issue. We believe our efforts around … Read more
An international cohort of OHDSI collaborators obtained a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network. The Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, … Read more
With the world fighting the SARS-CoV-2 pandemic and dealing with rapidly growing numbers of COVID-19 patients worldwide, clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, and if certain treatments are safe and effective. To this end, on 26-29 March, the Observational Health Data Sciences and Informatics (OHDSI) … Read more
The Observational Health Data Sciences and Informatics (OHDSI) international community will host a COVID-19 virtual study-a-thon this week (March 26-29) to inform healthcare decision-making in response to the current global pandemic. More than 290 people from 29 different countries have registered for the four-day online event, which will be led by researchers from Oxford University, … Read more
We regret to inform you that the 2020 European OHDSI Symposium “Form data to impact: the journey towards improving clinical practice” is cancelled due to the COVID-19 outbreak. Read the announcement here or visit www.ohdsi-europe.org for more information.
According to a recent OHDSI paper, chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic. The findings, published in JAMA Internal Medicine, contrast with current treatment guidelines recommending chlorthalidone over hydrochlorothiazide. The results were generated by the Large-Scale Evidence Generation and Evaluation in a Network … Read more
Between January 13 and 17, approximately 40 people of all disciplines, from clinical to academic to Data Partners (all with data mapped to the OMOP common data model) gathered in Barcelona for the second EHDEN study-a-thon. This time, research questions were situated in the domain of Rheumatoid Arthritis as we set out to evaluate the … Read more